Schistosomiasis control: Praziquantel forever?

Molecular and Biochemical Parasitology

Volumn 195, Issue 1, 2014, Pages 23-29

  Cioli, Donato ^a   Pica Mattoccia, Livia ^a   Basso, Annalisa ^a   Guidi, Alessandra ^a  

^a CNR   (Italy)

Author keywords

Drugs; Mechanism of action; Oxamniquine; Praziquantel; Resistance; Schistosomiasis

Indexed keywords

ANTIMALARIAL AGENT; FURAZOLIDONE; MOLLUSCACIDE; OXAMNIQUINE; PRAZIQUANTEL; SCHISTOSOMA VACCINE; ANTISCHISTOSOMAL AGENT;

ANTHELMINTIC ACTIVITY; BIOINFORMATICS; CALCIUM TRANSPORT; DRUG COST; DRUG DEVELOPMENT; DRUG EFFICACY; DRUG RESISTANCE; DRUG SAFETY; HIGH THROUGHPUT SCREENING; HUMAN; IN VITRO STUDY; INFECTION CONTROL; INFECTION RISK; LARVAL STAGE; MUSCLE CONTRACTION; PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TRAVEL; TREMATODE LIFE CYCLE STAGE; TURBELLARIA; ANIMAL; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; PARASITOLOGY; PHYSIOLOGY; SCHISTOSOMA;

MOLLUSCA;

ANIMALS; DRUG DISCOVERY; DRUG RESISTANCE; HUMANS; PRAZIQUANTEL; SCHISTOSOMA; SCHISTOSOMIASIS; SCHISTOSOMICIDES;

EID: 84904080868     PISSN: 01666851     EISSN: 18729428     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2014.06.002     Document Type: Review

References (69)

1. H. Kloos, and R. David The Paleoepidemiology of Schistosomiasis in Ancient Egypt Human Ecol Rev 9 2002 14 25 (Pubitemid 34657591)
2. L. Chitsulo, D. Engels, A. Montresor, and L. Savioli The global status of schistosomiasis and its control Acta Trop 77 2000 41 51
3. P. Steinmann, J. Keiser, R. Bos, M. Tanner, and J. Utzinger Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk Lancet Infect Dis 6 2006 411 425 (Pubitemid 43949139)
4. M.J. van der Werf, S.J. de Vlas, S. Brooker, C.W. Looman, N.J. Nagelkerke, and J.D. Habbema et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa Acta Trop 86 2003 125 139 (Pubitemid 36561364)
5. C.H. King, K. Dickman, and D.J. Tisch Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis Lancet 365 2005 1561 1569 (Pubitemid 40615405)
6. A.C. Evans, and L.S. Stephenson Not by drugs alone: the fight against parasitic helminths World Health Forum 16 1995 258 261 (Pubitemid 26465938)
7. H. Tanaka, and M. Tsuji From discovery to eradication of schistosomiasis in Japan: 1847-1996 Int J Parasitol 27 1997 1465 1480 (Pubitemid 28026755)
8. P. Minard, D.A. Dean, R.H. Jacobson, W.E. Vannier, and K.D. Murrell Immunization of mice with cobalt-60 irradiated Schistosoma mansoni cercariae Am J Trop Med Hyg 27 1978 76 86 (Pubitemid 8269673)
9. R.A. Wilson, and P.S. Coulson Schistosome vaccines: a critical appraisal Mem Inst Oswaldo Cruz 101 Suppl 1 2006 13 20 (Pubitemid 46143567)
10. J.M. Bethony, R.N. Cole, X. Guo, S. Kamhawi, M.W. Lightowlers, and A. Loukas et al. Vaccines to combat the neglected tropical diseases Immunol Rev 239 2011 237 270
11. R.F. Sturrock Schistosomiasis epidemiology and control: how did we get here and where should we go? Mem Inst Oswaldo Cruz 96 Suppl. 2001 17 27 (Pubitemid 33639547)
12. I. Takougang, J. Meli, and J. Wabo Poné Angwafo F 3rd. Community acceptability of the use of low-dose niclosamide (Bayluscide), as a molluscicide in the control of human schistosomiasis in Sahelian Cameroon Ann Trop Med Parasitol 101 2007 479 486 (Pubitemid 47489756)
13. K. Hostettmann, and P.J. Lea Biologically active natural products 1988 Oxford Science Publication Oxford, UK
14. S.H. Sokolow, K.D. Lafferty, and A.M. Kuris Regulation of laboratory populations of snails (Biomphalaria and Bulinus spp.) by river prawns, Macrobrachium spp. (Decapoda Palaemonidae): implications for control of schistosomiasis Acta Trop 132 2014 64 74
15. D. Cioli, L. Pica-Mattoccia, and S. Archer Antischistosomal drugs: past, present... and future? Pharmacol Ther 68 1995 35 85
16. D. Cioli, and L. Pica-Mattoccia Praziquantel Parasitol Res 90 Suppl. 1 2003 S3 S9
17. L. Pica-Mattoccia, and D. Cioli Praziquantel: too good to be replaced? C.R. Caffrey, Parasitic helminths targets, screens, drugs, and vaccines 2012 Wiley-Blackwell Weinheim 309 321
18. P. Andrews, H. Thomas, R. Pohlke, and J. Seubert Praziquantel Med Res Rev 3 1983 147 200
19. M.J. Doenhoff Is schistosomicidal chemotherapy sub-curative? Implications for drug resistance Parasitol Today 14 1998 434 435 (Pubitemid 28511208)
20. M. Ouldabdallahi, B. Ousmane, M. Ouldbezeid, D. Mamadou, L. Konaté, and L. Chitsulo Comparaison de l'efficacité thérapeutique et de la tolérance du praziquantel administré en prise unique à la dose de 40 versus 60 mg/kg pour le traitement de la bilharziose urinaire en Mauritanie Bull Soc Pathol Exot 106 2013 167 169
21. R. Gönnert, P. Andrews, and Praziquantel a new broad-spectrum antischistosomal agent Z Parasitenkd 52 1977 129 150
22. A.A. Sabah, C. Fletcher, G. Webbe, and M.J. Doenhoff Schistosoma mansoni: chemotherapy of infections of different ages Exp Parasitol 61 1986 294 303 (Pubitemid 16069841)
23. L. Pica-Mattoccia, and D. Cioli Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment Int J Parasitol 34 2004 527 533 (Pubitemid 38317176)
24. F.F. Stelma, I. Talla, S. Sow, A. Kongs, M. Niang, and K. Polman et al. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni Am J Trop Med Hyg 53 1995 167 170
25. E. Renganathan, and D. Cioli An international initiative on praziquantel use Parasitol Today 14 1998 390 391 (Pubitemid 28511198)
26. J. Utzinger, E.K. N'Goran, A. N'Dri, C. Lengeler, and M. Tanner Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection Trop Med Int Health 5 2000 771 778 (Pubitemid 32001036)
27. M.H. Wu, C.C. Wei, Z.Y. Xu, H.C. Yuan, W.N. Lian, and Q.J. Yang et al. Comparison of the therapeutic efficacy and side effects of a single dose of levo-praziquantel with mixed isomer praziquantel in 278 cases of schistosomiasis japonica Am J Trop Med Hyg 45 1991 345 349
28. T. Meyer, H. Sekljic, S. Fuchs, H. Bothe, D. Schollmeyer, and C. Miculka Taste a new incentive to switch to (R)-praziquantel in schistosomiasis treatment PLoS Negl Trop Dis 3 2009 e357 10.1371/journal.pntd.0000357
29. M. Woelfle, J.P. Seerden, J. de Gooijer, K. Pouwer, P. Olliaro, and M.H. Todd Resolution of praziquantel PLoS Negl Trop Dis 5 2011 e1260
30. J.Y. Chai Praziquantel treatment in trematode and cestode infections: an update Infect Chemother 45 2013 32 43
31. W. Wu, and Y. Huang Application of praziquantel in schistosomiasis japonica control strategies in China Parasitol Res 112 2013 909 915
32. J.T. Coulibaly, Y.K. N'gbesso, S. Knopp, J. Keiser, E.K. N'Goran, and J. Utzinger Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium PLoS Negl Trop Dis 6 2012 e1917
33. J.C. Sousa-Figueiredo, M. Betson, A. Atuhaire, M. Arinaitwe, A.M. Navaratnam, and N.B. Kabatereine et al. Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children PLoS Negl Trop Dis 6 2012 e1864
34. World Health Organization Report of the WHO informal consultation on the use of praziquantel during pregnancy/lactation and albendazole/mebendazole in children under 24 months Geneva, 8-9 April 2002 2003 WHO
35. S.Y. Kyung, Y.K. Cho, Y.J. Kim, J.W. Park, S.H. Jeong, and J.I. Lee et al. A paragonimiasis patient with allergic reaction to praziquantel and resistance to triclabendazole: successful treatment after desensitization to praziquantel Korean J Parasitol 49 2011 73 77
36. World Health Organization Weekly epidemiological record 89 2014 21 28
37. A. Montresor, D. Engels, L. Chitsulo, D.A. Bundy, S. Brooker, and L. Savioli Development and validation of a 'tablet pole' for the administration of praziquantel in sub-Saharan Africa Trans R Soc Trop Med Hyg 95 2001 542 544 (Pubitemid 34947414)
38. P.J. Hotez, D. Engels, A. Fenwick, and L. Savioli Africa is desperate for praziquantel Lancet 376 2010 496 498
39. J.A. van Wyk Refugia - overlooked as perhaps the most potent factor concerning the development of anthelmintic resistance Onderstepoort J Vet Res 68 2001 55 67 (Pubitemid 33405766)
40. M. Ismail, A. Metwally, A. Farghaly, J. Bruce, L.F. Tao, and J.L. Bennett Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel Am J Trop Med Hyg 55 1996 214 218 (Pubitemid 26299209)
41. S. Botros, H. Sayed, N. Amer, M. El-Ghannam, J.L. Bennett, and T.A. Day Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt Int J Parasitol 35 2005 787 791 (Pubitemid 40733617)
42. A. Guidi, C. Andolina, S. Makame Ame, M. Albonico, D. Cioli, and H. Juma Haji Praziquantel efficacy and long-term appraisal of schistosomiasis control in Pemba Island Trop Med Int Health 15 May (5) 2010 614 618
43. A.A. Sabah, C. Fletcher, G. Webbe, and M.J. Doenhoff Schistosoma mansoni: reduced efficacy of chemotherapy in infected T-cell-deprived mice Exp Parasitol 60 1985 348 354 (Pubitemid 16178911)
44. D. Cioli, S.S. Botros, K. Wheatcroft-Francklow, A. Mbaye, V. Southgate, and L.A. Tchuenté et al. Determination of ED50 values for praziquantel in praziquantel-resistant and -susceptible Schistosoma mansoni isolates Int J Parasitol 34 2004 979 987 (Pubitemid 38813260)
45. P.G. Fallon, and M.J. Doenhoff Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific Am J Trop Med Hyg 51 1994 83 88 (Pubitemid 24266292)
46. L. Pica-Mattoccia, M.J. Doenhoff, C. Valle, A. Basso, A.R. Troiani, and P. Liberti et al. Genetic analysis of decreased praziquantel sensitivity in a laboratory strain of Schistosoma mansoni Acta Trop 111 2009 82 85
47. F.F. Couto, P.M. Coelho, N. Araújo, J.R. Kusel, N. Katz, and L.K. Jannotti-Passos et al. Schistosoma mansoni: a method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails Mem Inst Oswaldo Cruz 106 2011 153 157
48. 2+ channels targets of praziquantel action? Int J Parasitol 35 2005 1 9 (Pubitemid 41556666)
49. 2+ channel beta subunits: subversion of flatworm regenerative polarity PLoS Negl Trop Dis 3 2009 e464
50. 2+ entry phenologs predict new anti-schistosomal agents PLoS Pathog 10 2014 e1003942
51. L. Pica-Mattoccia, C. Valle, A. Basso, A.R. Troiani, F. Vigorosi, and P. Liberti et al. Cytochalasin D abolishes the schistosomicidal activity of praziquantel Exp Parasitol 115 2007 344 351 (Pubitemid 46186312)
52. L. Pica-Mattoccia, T. Orsini, A. Basso, A. Festucci, P. Liberti, and A. Guidi et al. Schistosoma mansoni: lack of correlation between praziquantel-induced intra-worm calcium influx and parasite death Exp Parasitol 119 2008 332 335
53. F. Angelucci, A.E. Miele, G. Boumis, M. Brunori, D. Dimastrogiovanni, and A. Bellelli Macromolecular bases of antischistosomal therapy Curr Top Med Chem 11 2011 2012 2028
54. F. Ronketti, A.V. Ramana, X. Chao-Ming, L. Pica-Mattoccia, D. Cioli, and M.H. Todd Praziquantel derivatives I: modification of the aromatic ring Bioorg Med Chem Lett 17 2007 4154 4157 (Pubitemid 47021412)
55. Y. Dong, J. Chollet, M. Vargas, N.R. Mansour, Q. Bickle, and Y. Alnouti et al. Praziquantel analogs with activity against juvenile Schistosoma mansoni Bioorg Med Chem Lett 20 2010 2481 2484
56. P.S. Sadhu, S.N. Kumar, M. Chandrasekharam, L. Pica-Mattoccia, D. Cioli, and V.J. Rao Synthesis of new praziquantel analogues: potential candidates for the treatment of schistosomiasis Bioorg Med Chem Lett 22 2012 1103 1106
57. L. Pica-Mattoccia, L.C. Dias, R. Moroni, and D. Cioli Schistosoma mansoni: genetic complementation analysis shows that two independent hycanthone/oxamniquine-resistant strains are mutated in the same gene Exp Parasitol 77 1993 445 449
58. D. Cioli, and L. Pica-Mattoccia Current and future antischistosomal drugs W.E. Secor, D.G. Colley, Schistosomiasis, world class parasites series vol. 10 2005 Springer New York 191 206
59. L. Pica-Mattoccia, D. Carlini, A. Guidi, V. Cimica, F. Vigorosi, and D. Cioli The schistosome enzyme that activates oxamniquine has the characteristics of a sulfotransferase Mem Inst Oswaldo Cruz 101 Suppl. 1 2006 307 312 (Pubitemid 46143610)
60. C.L. Valentim, D. Cioli, F.D. Chevalier, X. Cao, A.B. Taylor, and S.P. Holloway et al. Genetic and molecular basis of drug resistance and species-specific drug action in schistosome parasites Science 342 2013 1385 1389
61. L. Pérez del Villar, F.J. Burguillo, J. López-Abán, and A. Muro Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis PLoS ONE 7 2012 e45867
62. J. Keiser, K. Ingram, M. Vargas, J. Chollet, X. Wang, and Y. Dong et al. In vivo activity of aryl ozonides against Schistosoma species Antimicrob Agents Chemother 56 2012 1090 1092
63. L. Van Nassauw, S. Toovey, J. Van Op den Bosch, J.P. Timmermans, and J. Vercruysse Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice Travel Med Infect Dis 6 2008 253 258
64. H.M. Alger, and D.L. Williams The disulfide redox system of Schistosoma mansoni and the importance of a multifunctional enzyme, thioredoxin glutathione reductase Mol Biochem Parasitol 121 2002 129 139 (Pubitemid 34457840)
65. F. Angelucci, D. Dimastrogiovanni, G. Boumis, M. Brunori, A.E. Miele, and F. Saccoccia et al. Mapping the catalytic cycle of Schistosoma mansoni thioredoxin glutathione reductase by X-ray crystallography J Biol Chem 285 2010 32557 32567
66. A.A. Sayed, A. Simeonov, C.J. Thomas, J. Inglese, C.P. Austin, and D.L. Williams Identification of oxadiazoles as new drug leads for the control of schistosomiasis Nat Med 14 2008 407 412 (Pubitemid 351499390)
67. F. Agüero, B. Al-Lazikani, M. Aslett, M. Berriman, F.S. Buckner, and R.K. Campbell et al. Genomic-scale prioritization of drug targets: the TDR Targets database Nat Rev Drug Discov 7 2008 900 907
68. H. You, D.P. McManus, W. Hu, M.J. Smout, P.J. Brindley, and G.N. Gobert Transcriptional responses of in vivo praziquantel exposure in schistosomes identifies a functional role for calcium signalling pathway member CamKII PLoS Pathog 9 2013 e1003254
69. R.A. Paveley, and Q.D. Bickle Automated imaging and other developments in whole-organism anthelmintic screening, Parasite Immunol 35 2013 302 313